This meeting will connect a broad network of researchers who share a common goal of using CRISPR-based genome engineering approaches to understand and treat human disease. Specifically, the program will bridge early stage research focused on developing and using CRISPR tools to understand disease mechanisms, through applications of these technologies in preclinical models and current therapeutic strategies for oncology and genetic disease.